Detalhe da pesquisa
1.
Survival after neoadjuvant/induction combination immunotherapy vs combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancer.
Int J Cancer
; 151(11): 2004-2011, 2022 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35603905
2.
Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration.
World J Urol
; 40(5): 1167-1174, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35218372
3.
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.
World J Urol
; 40(11): 2707-2715, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36169695
4.
18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancer.
Curr Opin Urol
; 30(5): 654-664, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32701719
5.
Reply to: Comments on "Neoadjuvant/induction combination immunotherapy vs combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancer".
Int J Cancer
; 151(10): 1849-1850, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35815942
6.
The Implementation of FDG PET/CT for Staging Bladder Cancer: Changes in the Detection and Characteristics of Occult Nodal Metastases at Upfront Radical Cystectomy?
J Clin Med
; 12(10)2023 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37240473
7.
Staging 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Changes Treatment Recommendation in Invasive Bladder Cancer.
Eur Urol Oncol
; 5(3): 366-369, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33583752
8.
Re: Neoadjuvant PD-L1 plus CTLA-4 Blockade in Patients with Cisplatin-ineligible Operable High-risk Urothelial Carcinoma.
Eur Urol
; 83(1): 91-92, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36210214